BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29753869)

  • 1. Dexamethasone alleviates pemetrexed-induced senescence in Non-Small-Cell Lung Cancer.
    Ge H; Ke J; Xu N; Li H; Gong J; Li X; Song Y; Zhu H; Bai C
    Food Chem Toxicol; 2018 Sep; 119():86-97. PubMed ID: 29753869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone reduces sensitivity to cisplatin by blunting p53-dependent cellular senescence in non-small cell lung cancer.
    Ge H; Ni S; Wang X; Xu N; Liu Y; Wang X; Wang L; Song D; Song Y; Bai C
    PLoS One; 2012; 7(12):e51821. PubMed ID: 23272171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo.
    Yang W; Yang L; Xia Y; Cheng L; Zhang J; Meng F; Yuan J; Zhong Z
    Acta Biomater; 2018 Apr; 70():177-185. PubMed ID: 29410335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen.
    Wang LJ; Li J; Hao FR; Yuan Y; Li JY; Lu W; Zhou TY
    Acta Pharmacol Sin; 2016 Jun; 37(6):845-56. PubMed ID: 27133297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic p27
    Patki M; McFall T; Rosati R; Huang Y; Malysa A; Polin L; Fielder A; Wilson MR; Lonardo F; Back J; Li J; Matherly LH; Bepler G; Ratnam M
    Sci Rep; 2018 Oct; 8(1):16006. PubMed ID: 30375484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemetrexed: a multitargeted antifolate.
    Rollins KD; Lindley C
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.
    Shukuya T; Ko R; Mori K; Kato M; Yagishita S; Kanemaru R; Honma Y; Shibayama R; Koyama R; Shimada N; Takahashi K
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):771-6. PubMed ID: 26259641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenografts.
    Cui J; Zhang Y; Su D; Li T; Li Y
    Thorac Cancer; 2018 Sep; 9(9):1156-1165. PubMed ID: 30047610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
    Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
    Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase.
    Kuo WT; Tu DG; Chiu LY; Sheu GT; Wu MF
    Oncol Rep; 2017 Nov; 38(5):2787-2795. PubMed ID: 28901493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H9 Inhibits Tumor Growth and Induces Apoptosis via Intrinsic and Extrinsic Signaling Pathway in Human Non-Small Cell Lung Cancer Xenografts.
    Kim MJ; Kwon SB; Ham SH; Jeong ES; Choi YK; Choi KD; Hong JT; Jung SH; Yoon DY
    J Microbiol Biotechnol; 2015 May; 25(5):648-57. PubMed ID: 25639715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Radiolabeled 3'-Deoxy-3'-
    McHugh CI; Thipparthi MR; Lawhorn-Crews JM; Polin L; Gadgeel S; Akoury J; Mangner TJ; Douglas KA; Li J; Ratnam M; Shields AF
    J Nucl Med; 2018 Oct; 59(10):1544-1550. PubMed ID: 29674424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC).
    Garrido P; Engel-Riedel W; Serke M; Giraud P; Ricardi U; Vallejo C; Visseren-Grul C; Ameryckx S; Soldatenkova V; Chouaki N; Novello S
    Lung Cancer; 2015 May; 88(2):160-6. PubMed ID: 25758556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cells.
    Okimoto T; Kotani H; Iida Y; Koyanagi A; Tanino R; Tsubata Y; Isobe T; Harada M
    Cancer Sci; 2020 Jun; 111(6):1910-1920. PubMed ID: 32232903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.
    Ding X; Gu Y; Jin M; Guo X; Xue S; Tan C; Huang J; Yang W; Xue M; Zhou Q; Wang W; Zhang Y
    Theranostics; 2020; 10(13):6048-6060. PubMed ID: 32483437
    [No Abstract]   [Full Text] [Related]  

  • 16. Delivery of pemetrexed by magnetic nanoparticles: design, characterization,
    Ak G; Aksu D; Çapkın E; Sarı Ö; Kımız Geboloğlu I; Şanlıer ŞH
    Prep Biochem Biotechnol; 2020; 50(3):215-225. PubMed ID: 31750758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide (NO) enhances pemetrexed cytotoxicity via NO‑cGMP signaling in lung adenocarcinoma cells in vitro and in vivo.
    Nagai H; Yasuda H; Hatachi Y; Xue D; Sasaki T; Yamaya M; Sakamori Y; Togashi Y; Masago K; Ito I; Kim YH; Mio T; Mishima M
    Int J Oncol; 2012 Jul; 41(1):24-30. PubMed ID: 22552400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of histology on efficacy of pemetrexed: pemetrexed in second-line setting and as maintenance therapy after first-line treatment in Chinese patients with advanced NSCLC].
    Zhou C; Wu Y; Sun Y; Wang Y; Wang X; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):29-33. PubMed ID: 24685083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT.
    Tièche CC; Peng RW; Dorn P; Froment L; Schmid RA; Marti TM
    BMC Cancer; 2016 Feb; 16():125. PubMed ID: 26895954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
    Tung CL; Chiu HC; Jian YJ; Jian YT; Chen CY; Syu JJ; Wo TY; Huang YJ; Tseng SC; Lin YW
    Exp Cell Res; 2014 Apr; 322(2):345-54. PubMed ID: 24530475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.